Convelo Therapeutics
Convelo
About Us Approach Team News Publications Careers Contact
Convelo
Convelo Therapeutics
About UsApproachTeamNewsPublicationsCareersContact
Drug-based modulation of endogenous stem cells promotes functional remyelination in vivo

Najm FJ, Madhavan M, Zaremba A, Shick E, Karl RT, Factor DC, Miller TE, Nevin ZS, Kantor C, Sargent A, Quick KL, Schlatzer DM, Tang H, Papoian R, Brimacombe KR, Shen M, Boxer MB, Jadhav A, Robinson AP, Podojil JR, Miller SD, Miller RH, Tesar PJ.
Nature

Paul TesarApril 20, 2015
Facebook0 Twitter 0 Likes
Previous

Modeling the Mutational and Phenotypic Landscapes of Pelizaeus-Merzbacher Disease with Human iPSC-Derived Oligodendrocytes

Paul TesarMarch 30, 2017
Next

Transcription factor-mediated reprogramming of fibroblasts to expandable, myelinogenic oligodendrocyte progenitor cells

Paul TesarApril 14, 2013

Hours
convelo_logo_color.png

11000 Cedar Avenue
Cleveland, OH 44106

 

Copyright © 2018 Convelo Therapeutics, Inc. All Rights Reserved.